781 DELTA-2: A phase 1, open-label, multicenter study of ITIL-168, an autologous tumor-infiltrating lymphocyte (TIL) cell therapy, with pembrolizumab in patients with advanced solid tumors
O. Yeku, D. Olson, J. Ward, S. Patel, J. Aycock, Amber C. Donahue, Yi-zhou Jiang, J. Gall, Z. Roberts, Rubén Álvarez-Rodríguez, Judy Seng, Tong Shen, N. Kothari
{"title":"781 DELTA-2: A phase 1, open-label, multicenter study of ITIL-168, an autologous tumor-infiltrating lymphocyte (TIL) cell therapy, with pembrolizumab in patients with advanced solid tumors","authors":"O. Yeku, D. Olson, J. Ward, S. Patel, J. Aycock, Amber C. Donahue, Yi-zhou Jiang, J. Gall, Z. Roberts, Rubén Álvarez-Rodríguez, Judy Seng, Tong Shen, N. Kothari","doi":"10.1136/jitc-2022-sitc2022.0781","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":398566,"journal":{"name":"Regular and Young Investigator Award Abstracts","volume":"23 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Regular and Young Investigator Award Abstracts","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/jitc-2022-sitc2022.0781","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
